Last reviewed · How we verify
NCT04837456
Metabolic Syndrome and Degenerate Meniscus Tears
NA trial testing Calorie restricted diet and exercise intervention in Metabolic Syndrome in 189 participants. Completed in 1 March 2021.
1 March 2020
Quick facts
| Lead sponsor | The First People's Hospital of Jingzhou |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | treatment |
| Enrollment | 189 |
| Start date | 1 June 2017 |
| Primary completion | 1 March 2020 |
| Estimated completion | 1 March 2021 |
| Sites | 1 location across China |
Drugs / interventions tested
- Calorie restricted diet and exercise intervention
- libitum diet and waiting list control group
- Early arthroscopic partial menisectomy group
- delayed APM group recruit participants with symptoms lasting for more than 6 months
Conditions studied
- Metabolic Syndrome — all drugs for Metabolic Syndrome →
- Meniscus; Degeneration — all drugs for Meniscus; Degeneration →
Sponsor
The First People's Hospital of Jingzhou
Who can join
Adults 35 to 70, any sex, with Metabolic Syndrome or Meniscus; Degeneration. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The aim is to determine the outcomes of calorie-restricted diet and exercise intervention; libitum diet and waiting list control; early arthroscopic partial meniscectomy(APM) or delayed APM effect on MetS patients with Degenerate menisucus lesions.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Arthroscopic surgery for degenerative knee disease (osteoarthritis including degenerative meniscal tears).
O'Connor D, Johnston RV, Brignardello-Petersen R, Poolman RW, et al · · 2022 · cited 33× · PMID 35238404 · DOI 10.1002/14651858.cd014328
Verify or expand the search:
- PubMed search for NCT04837456
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Metabolic Syndrome
Currently open trials in the same condition.
- NCT07501858 — Assessing the Association Between H. Pylori Persistence and the Severity of Insulin Resistance in Patients With Metaboli · recruiting
- NCT06857929 — "Improving Health and Reducing Chronic Disease Risk in Middle-Aged Adults Through Nutrition" · NA · recruiting
- NCT07237750 — iWAIST Trial: ERCG (Endoscopic Radial Compression Gastroplasty) vs Optimized Lifestyle Intervention for Weight Loss · NA · recruiting
- NCT07406191 — WB-EMS Effects on Cardiometabolic Risk Factors · NA · recruiting
- NCT07383220 — Effect of Electrical Stimulation and Exercise on Blood Flow in Patients With Resistant High Blood Pressure · NA · recruiting
Other The First People's Hospital of Jingzhou trials
Trials by the same sponsor.
- NCT06868004 — Holistic Nursing Benefits Cognitive and Psychiatric Symptoms in Alzheimer's Patients · NA · completed
- NCT05092178 — Calorie Restricted Diet and Exercise · NA · completed
- NCT05114694 — Early Arthroscopic Partial Meniscectomy(APM) · NA · unknown
- NCT04921202 — Metabolic Syndrome and Degenerative Meniscus Lesions Related Knee Function · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04837456 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 9 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by The First People's Hospital of Jingzhou
- Last refreshed: 8 April 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04837456.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing